(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3,222.51%72.63M | -173.35%-6.16M | -186.64%-7.93M | -77.11%19.76M | -226.97%-9.22M | -90.69%2.19M | 8.4M | 9.16M | 86.32M | 7.26M |
Net income from continuing operations | 32.86%-127.16M | 316.94%16.42M | 95.65%-842K | -3,779.92%-191.54M | 242.61%13.27M | -18,340.60%-189.39M | --3.94M | ---19.36M | --5.21M | ---9.3M |
Operating gains losses | -89.21%1.63M | 118.29%568K | ---- | 76.01%22.28M | -109.94%-369K | 407.84%15.15M | ---3.11M | --10M | --12.66M | --3.71M |
Depreciation and amortization | 38.93%15.6M | 52.97%13.12M | 55.89%14.25M | -14.37%45.67M | 71.37%16.68M | -10.36%11.23M | --8.58M | --9.14M | --53.33M | --9.73M |
Asset impairment expenditure | --0 | ---- | ---- | --19.62M | --0 | --19.62M | ---- | ---- | --0 | --0 |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---22.53M | ---- |
Unrealized gains and losses of investment securities | 2,331.25%5.84M | -149.33%-329K | 55.58%1.78M | -68.58%3.09M | -88.14%1.03M | -51.22%240K | --667K | --1.15M | --9.82M | --8.72M |
Remuneration paid in stock | -47.77%818K | 85.52%2.01M | 75.21%2.13M | -13.90%7.27M | -27.60%2.01M | -43.63%1.57M | --1.08M | --1.21M | --8.44M | --2.78M |
Deferred tax | 146.68%42.9M | 158.04%19.66M | -3.73%13.47M | -87.87%5.96M | -337.68%-33.04M | 85.78%17.39M | --7.62M | --13.99M | --49.11M | --13.9M |
Other non cashItems | 68.74%147.55M | 27.74%5.42M | 76.99%7.21M | 388.08%107.7M | 226.37%12.54M | 2,737.09%87.44M | --4.24M | --4.08M | --22.07M | --3.84M |
Change In working capital | -115.19%-7.07M | -1,117.76%-42.36M | -311.41%-45.44M | 572.68%25.14M | -395.31%-17.56M | 837.95%46.54M | --4.16M | ---11.05M | ---5.32M | --5.95M |
-Change in receivables | -1,726.30%-24.05M | -186.91%-10.03M | 242.04%1.53M | 108.31%1.85M | -8.70%-5.35M | 114.54%1.48M | --11.54M | ---1.08M | ---22.23M | ---4.92M |
-Change in inventory | -6,803.04%-20.43M | -41.92%-22.94M | -137.97%-3.17M | -757.04%-26.12M | -165.26%-18.01M | 97.76%-296K | ---16.16M | --8.34M | --3.98M | --27.59M |
-Change in payables and accrued expense | -17.51%37.42M | -206.91%-9.39M | -139.32%-43.81M | 281.99%49.42M | 134.65%5.79M | 60.09%45.36M | --8.78M | ---18.31M | --12.94M | ---16.72M |
Tax refund paid | 1.71%-7.47M | -10.01%-20.67M | ---486K | 45.30%-25.41M | 60.42%-3.77M | 34.86%-7.6M | ---18.78M | --0 | ---46.46M | ---9.54M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3,222.51%72.63M | -173.35%-6.16M | -186.64%-7.93M | -77.11%19.76M | -226.97%-9.22M | -90.69%2.19M | --8.4M | --9.16M | --86.32M | --7.26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -94.55%-54.25M | -76.67%-40.39M | 9.23%-21.37M | -133.32%-95.52M | -239.27%-19.93M | 38.22%-27.88M | -22.86M | -23.54M | -40.94M | 14.31M |
Net PPE purchase and sale | -184.19%-46.08M | -127.70%-38.3M | -6.38%-19.72M | -27.85%-70.79M | -6,628.23%-19.19M | 39.35%-16.22M | ---16.82M | ---18.54M | ---55.37M | --294K |
Interest received (cash flow from investment activities) | ---6.32M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | 84.21%-1.84M | 65.40%-2.09M | 67.04%-1.65M | -271.33%-24.73M | -105.24%-735K | 36.57%-11.67M | ---6.04M | ---5.01M | --14.43M | --14.02M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -94.55%-54.25M | -76.67%-40.39M | 9.23%-21.37M | -133.32%-95.52M | -239.27%-19.93M | 38.22%-27.88M | ---22.86M | ---23.54M | ---40.94M | --14.31M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.55%935K | -106.02%-337K | -1.47%-3.86M | 504.27%193.46M | -196.63%-10.12M | 7,396.06%209.47M | 5.6M | -3.8M | -47.85M | -3.41M |
Net issuance payments of debt | --0 | --0 | --0 | 243.03%54.09M | -233.01%-10.2M | --65.85M | --7.62M | ---1.5M | ---37.81M | ---3.06M |
Net common stock issuance | --0 | ---- | ---- | --160M | --0 | --160M | ---- | ---- | --0 | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | --0 | 83.37%-337K | -154.92%-4.69M | 25.67%-5.3M | --138K | -13.73%-1.87M | ---2.03M | ---1.84M | ---7.13M | --0 |
Net other financing activities | 106.44%935K | ---- | 280.52%834K | -427.13%-15.33M | 83.91%-56K | -1,084.49%-14.51M | ---- | ---462K | ---2.91M | ---348K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.55%935K | -106.02%-337K | -1.47%-3.86M | 504.27%193.46M | -196.63%-10.12M | 7,396.06%209.47M | --5.6M | ---3.8M | ---47.85M | ---3.41M |
Net cash flow | ||||||||||
Beginning cash position | 392.27%77.97M | 390.50%125.37M | 251.26%158.64M | -20.21%45.16M | 560.28%198.57M | -72.10%15.84M | --25.56M | --45.16M | --56.6M | --30.07M |
Current changes in cash | -89.49%19.32M | -428.60%-46.89M | -82.30%-33.16M | 4,865.14%117.7M | -316.24%-39.26M | 849.63%183.77M | ---8.87M | ---18.19M | ---2.47M | --18.16M |
Effect of exchange rate changes | -84.76%-1.92M | 39.48%-515K | 92.29%-109K | 52.91%-4.22M | 78.10%-672K | 52.54%-1.04M | ---851K | ---1.41M | ---8.97M | ---3.07M |
End cash Position | -51.97%95.37M | 392.27%77.97M | 390.51%125.37M | 251.26%158.64M | 251.26%158.64M | 560.28%198.57M | --15.84M | --25.56M | --45.16M | --45.16M |
Free cash from | 289.24%26.55M | -427.78%-44.46M | -194.76%-27.65M | -932.09%-51.03M | -64.54%-28.41M | -332.19%-14.03M | ---8.42M | ---9.38M | --6.13M | ---17.27M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data